Skip to content

Artificial protein builds autonomous circuits to control any cellular process.

Bio-computers use systems of biologically derived molecules, such as DNA and proteins, to build circuitry inside cells which can perform computational calculations involving storing, retrieving, and processing data. In turn, it is hoped these ‘smart cells’ will lead to smart drugs, living computers inside the body which are able to monitor, target and treat the host body and disease autonomously. Now, a study from researchers led by UC San Francisco develops a transformative biotechnology enabling the construction of biological circuits which gives cells unprecedented capabilities. The team states the novel artificial protein can be used to build brand-new biological circuits inside living cells, transforming ordinary cells into smart cells endowed with autonomous abilities. The two studies are published in the journal Nature, whose links can be found here and here.

Previous studies show many therapies are safe and effective only when administered at the right time and in very precise doses, when given too early or too late, is too large or too small an amount, medicines can be ineffective or even harmful. Patient adherence can also be a problem with drug efficacy, with monitoring systems also desirable to detect any problems or diseases. The current study develops smart cells exhibiting behaviour similar to tiny autonomous robots with the potential to detect damage and disease, and deliver drugs as and when needed.

The current study designs an artificial protein on a computer, capable of building brand-new biological circuits inside living cells once synthesized. Results show the protein, dubbed the Latching Orthogonal Cage-Key pRotein, or LOCKR resembles a barrel containing a molecular arm possessing the ability to control virtually any cellular process once activated. Data findings show the arms can direct molecular traffic inside cells, degrade specific proteins, and initiate the cell’s self-destruct process.

The lab also developed a version of the protein called degronLOCKR, which can be switched on and off to degrade a protein of interest and can construct circuits to dynamically regulate cellular activity in response to cues from the cell’s internal and external environments. Results show when the circuits, which include a genetically encoded sensor, detects a disruption of normal cell activity, degronLOCKR responds by destroying the proteins causing the disruption to the cellular software, until the cell returns to normal.

The team surmises they have engineered proteins for generating complex synthetic circuitry in cells for biotechnological and therapeutic applications. For the future, the researchers plan to transform cells in vivo into smart cells by installing degronLOCKR-based circuits, to treat a variety of diseases and ailments, including traumatic brain injury.

Source: University of California San Francisco

 

Get Healthinnovations delivered to your inbox:

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »